Effect of Metformin on tau pathology and proteostasis in cellular and a Drosophila model of Tauopathy

Topic: Disease mechanisms in lab and animal studies

Alzheimer’s disease is increasingly linked to metabolic dysfunction, with insulin resistance emerging as a key contributor to tau pathology. The antidiabetic drug Metformin has shown conflicting effects in neurodegeneration, underscoring the need to resolve its mechanistic impact on tau regulation. This study combines insulin-resistant neuroblastoma cells with Drosophila models of tauopathy to define how Metformin modulates tau phosphorylation via underlying signalling pathways. Metformin treatment increased total tau levels while consistently reducing hyperphosphorylated tau at disease-relevant epitopes in endogenous neuroblastoma cells. This dissociation was associated with enhanced activation of AKT and AMPK signalling and maintenance of basal phosphatase activity. We further observed that Metformin at low concentrations promoted autophagic activity, whereas higher concentrations impaired autophagic clearance. In the Tauopathy models, Metformin selectively ameliorated tau-induced neurodegeneration and tau-hyperphosphorylation in tau-0N4R but not in more pathogenic tau variants (tau-2N4R and tau-E14). The alteration in pathological tau levels did not correlate directly with the status of autophagy. On the contrary, autophagic status was influenced by diet and sex of these organisms. Together, our findings demonstrate that Metformin modulates tau phosphorylation independently of total tau levels and reveals a critical dissociation between upstream metabolic signalling and downstream proteostatic outcomes.

Key findings

• This dissociation was associated with enhanced activation of AKT and AMPK signalling and maintenance of basal phosphatase activity.
• Together, our findings demonstrate that Metformin modulates tau phosphorylation independently of total tau levels and reveals a critical dissociation between upstream metabolic signalling and downstream proteostatic outcomes.

New to this subject? Start with our plain-English guide: Treatments →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.21203/rs.3.rs-10786020/v1
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{paruchuri2026-a6042b4b,
  author  = {Paruchuri, S. and Sivanantharajah, L. and Mudher, A. and Chatterjee, S.},
  title   = {{Effect of Metformin on tau pathology and proteostasis in cellular and a Drosophila model of Tauopathy}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10786020/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10786020/v1}
}

Related studies in Drug development

• The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy Brain research · 2015-12-31 · usefulness score 41/100
• TauLUM, an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy Cell reports methods · 2022-09-09 · usefulness score 41/100
• Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease PLoS genetics · 2010-09-02 · usefulness score 40/100
• Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice Science translational medicine · 2024-07-03 · usefulness score 43/100
• Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models PloS one · 2015-05-01 · usefulness score 40/100
• Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model Frontiers in aging neuroscience · 2020-01-14 · usefulness score 39/100

Also tagged “phosphorylation”

387 studies in the library carry the topic tag “phosphorylation”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 387 tagged studies.

• Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1 The Journal of biological chemistry · 1988-06-01 · usefulness score 36/100 · Drug development
• Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies Neuron · 2018-11-01 · usefulness score 38/100 · Genetics
• Biomarker-related phospho-tau217 appears in synapses around Aβ plaques prior to tau tangle in cerebral cortex of preclinical Alzheimer's disease Cell reports · 2025-09-02 · usefulness score 43/100 · Biomarkers

Similar studies

• Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling 2010 · Drug development
• Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice 2012 · Drug development
• Reduced expression of dMyc mitigates TauV337M mediated neurotoxicity by preventing the Tau hyperphosphorylation and inducing autophagy in Drosophila 2020 · Disease mechanisms
• Early Insulin Signaling Abnormalities and Oxidative Stress Responses in PS19 Tau Transgenic Mice 2026 · Inflammation and the immune system
• Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice 2023 · Drug development
• Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice 2021 · Drug development

More on Drug development

• A review that covers this ground Synergistic Effect of Amyloid-β and Tau Disrupts Neural Circuits ACS chemical neuroscience · 2019-01-31 · usefulness score 39/100
• Newest in this subject The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration Metabolism: clinical and experimental · 2026-10-30 · Peer-reviewed · usefulness score 45/100
• Newest in this subject Beyond Glycemic Control: The Pleiotropic Role of GLP-1RAs and Melatonin in Combating Neuroinflammation and Mitochondrial Dysfunction Preprints.org · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Drug development →